MedTrace Logo

Capsaicin 8% Patch for Spinal Cord Injury Neuropathic Pain

NCT02441660 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 11

Last updated 2023-01-26

Study results available
· View outcomes & findings →

Summary

A prospective case control study to determine the effectiveness and longevity of 8% capsaicin patch(es) in treating neuropathic pain in persons with spinal cord injury. The investigators will study spinal cord injury patients at South Texas Veterans Health Care Systems Spinal Cord Injury inpatient unit and outpatient clinics.

Conditions

  • Spinal Cord Injuries
  • Neuropathic Pain

Interventions

DRUG

Capsaicin 8% Patch

Applied topically for 1 hour

DRUG

Low Dose Capsaicin 0.025% Well Patch

Sponsors & Collaborators

  • The University of Texas Health Science Center at San Antonio

    lead OTHER

Principal Investigators

  • Michelle Trbovich, MD · South Texas Veterans Health Care System

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-04-30
Primary Completion
2021-07-31
Completion
2022-05-02

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02441660 on ClinicalTrials.gov